Build **EpiLock AI**, a $12K/year **Healthtech SaaS + IoT + blockchain platform** that **deploys ultra-cold chain sensors and AI-driven logistics** to **auto-track, secure, and monetize high-value biologics** (vaccines, cell therapies, lab samples). The platform would: (1) **Deploy ‘BioSense’ nodes** ($1.5K/unit): Raspberry Pi + cryogenic sensors (-80°C to +20°C) with edge AI (Jetson Orin) to auto-detect excursions (e.g., ‘Vial #XYZ: +0.3°C—reroute to backup fridge’); (2) **Provide ‘OutbreakIQ’**: Real-time pathogen tracking via WHO/CDC APIs (e.g., ‘Ebola: +3 cases in Kinshasa—trigger emergency protocol’); (3) **Integrate with ‘Cold Chain APIs’** (DHL, Maersk) to auto-route shipments (e.g., ‘DHL: 98% on-time delivery—use for $1M+ contracts’); (4) **Offer ‘Compliance Firewall’**: Auto-generates FDA 21 CFR Part 11 and EU GDPR reports (e.g., ‘FDA Form 483: 100% compliant—submit’); (5) **Include ‘Biologics Marketplace’**: Monetizes unused cold chain capacity (e.g., ‘Your -80°C freezer: $5K/year in shared revenue’).

Mid-market biotech startups and NGOs lack the $50M+ budgets of Big Pharma (e.g., Merck’s Ebola vaccine R&D) but face identical challenges: **ultra-cold chain logistics, real-time pathogen tracking, and regulatory compliance**. Current solutions (Excel, FedEx Cold Chain) are manual, error-prone, and unable to scale during outbreaks. The financial cost of failure is catastrophic: (1) **$1B+ in lost vaccine doses** due to temperature excursions (WHO 2025); (2) **$500M/outbreak in emergency response costs** (CDC); (3) **$10M+/violation in FDA 21 CFR Part 11 fines** for mislabeled samples.